These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31391529)

  • 1. Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test.
    Tomas C; Lodge TA; Potter M; Elson JL; Newton JL; Morten KJ
    Sci Rep; 2019 Aug; 9(1):11464. PubMed ID: 31391529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Missailidis D; Sanislav O; Allan CY; Annesley SJ; Fisher PR
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
    Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function.
    Tomas C; Elson JL; Strassheim V; Newton JL; Walker M
    PLoS One; 2020; 15(4):e0231136. PubMed ID: 32275686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
    Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
    Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Esfandyarpour R; Kashi A; Nemat-Gorgani M; Wilhelmy J; Davis RW
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10250-10257. PubMed ID: 31036648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat treatment in health and disease: How water-filtered infrared-A (wIRA) irradiation affects key cellular mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients compared to healthy donors.
    Hochecker B; Molinski N; Matt K; Meßmer A; Scherer M; von Ardenne A; Bergemann J
    J Therm Biol; 2024 Feb; 120():103813. PubMed ID: 38412735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy.
    Xu J; Potter M; Tomas C; Elson JL; Morten KJ; Poulton J; Wang N; Jin H; Hou Z; Huang WE
    Analyst; 2019 Jan; 144(3):913-920. PubMed ID: 30207334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
    Maksoud R; Magawa C; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    BMC Med; 2023 May; 21(1):189. PubMed ID: 37226227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome.
    Tomas C; Brown A; Strassheim V; Elson JL; Newton J; Manning P
    PLoS One; 2017; 12(10):e0186802. PubMed ID: 29065167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
    PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-exertional symptoms distinguish Myalgic Encephalomyelitis/Chronic Fatigue Syndrome subjects from healthy controls.
    Mateo LJ; Chu L; Stevens S; Stevens J; Snell CR; Davenport T; VanNess JM
    Work; 2020; 66(2):265-275. PubMed ID: 32568143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Gravelsina S; Nora-Krukle Z; Vilmane A; Svirskis S; Vecvagare K; Krumina A; Murovska M
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.
    Mandarano AH; Maya J; Giloteaux L; Peterson DL; Maynard M; Gottschalk CG; Hanson MR
    J Clin Invest; 2020 Mar; 130(3):1491-1505. PubMed ID: 31830003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.
    Scherbakov N; Szklarski M; Hartwig J; Sotzny F; Lorenz S; Meyer A; Grabowski P; Doehner W; Scheibenbogen C
    ESC Heart Fail; 2020 Jun; 7(3):1064-1071. PubMed ID: 32154656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.